Escalated hyperfractionated accelerated radiation therapy for locally advanced non-small cell lung cancer: a clinical phase II trial
- 1 May 2004
- journal article
- clinical trial
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 71 (2) , 157-162
- https://doi.org/10.1016/j.radonc.2004.01.007
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Randomized chemoradiation for patients with locally advanced inoperable non-small cell lung cancer (NSCLC): Long-term follow-up of RTOG 92-04Lung Cancer, 2000
- Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trialRadiotherapy and Oncology, 1999
- Improved Survival in Stage III Non-Small-Cell Lung Cancer: Seven-Year Follow-up of Cancer and Leukemia Group B (CALGB) 8433 TrialJNCI Journal of the National Cancer Institute, 1996
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- Treatment-induced accelerated human tumor growthSeminars in Radiation Oncology, 1993
- Adding dose escalation to accelerated hyperfractionation for head and neck cancer: 76 Gy in 5 weeksSeminars in Radiation Oncology, 1992
- Accelerating hyperfractionation for carcinoma of the head and neckSeminars in Radiation Oncology, 1992
- Radiotherapy Alone Versus Combined Chemotherapy and Radiotherapy in Nonresectable Non-Small-Cell Lung Cancer: First Analysis of a Randomized Trial in 353 PatientsJNCI Journal of the National Cancer Institute, 1991
- The relationship between tumor response and survival following radiotherapy for carcinoma of the bronchusInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Clinical dose-response curves of human malignant epithelial tumoursThe British Journal of Radiology, 1973